BIOMAT Database Logo BIOMAT Database Logo

Determination of total cysteamine in human serum by a high-performance liquid chromatography with fluorescence detection. 1998

M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Laboratoire Central d'Analyses, Pharmacie Centrale des Hôpitaux, Paris, France.

A convenient, reliable and rapid method for determination of total cysteamine in human plasma by high-performance liquid chromatography with fluorescence detection is reported. This assay involves reduction of samples with dithiothreitol, derivatization of total cysteamine by addition of monobromobimane and protein precipitation by perchloric acid. The calibration curve was linear in the range 2-150 nmol ml-1 and the detection limit was 0.5 nmol ml-1. This method was successfully applied for a pharmacokinetic study of three cysteamine derivatives in healthy volunteers without any interference from coexisting substances.

UI MeSH Term Description Entries
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003543 Cysteamine A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS. Cysteinamine,Mercaptamine,2-Aminoethanethiol,Becaptan,Cystagon,Cysteamine Bitartrate,Cysteamine Dihydrochloride,Cysteamine Hydrobromide,Cysteamine Hydrochloride,Cysteamine Maleate (1:1),Cysteamine Tartrate,Cysteamine Tartrate (1:1),Cysteamine Tosylate,Cysteamine, 35S-Labeled,Mercamine,Mercaptoethylamine,beta-Mercaptoethylamine,2 Aminoethanethiol,35S-Labeled Cysteamine,Bitartrate, Cysteamine,Cysteamine, 35S Labeled,Dihydrochloride, Cysteamine,Hydrobromide, Cysteamine,Hydrochloride, Cysteamine,Tartrate, Cysteamine,Tosylate, Cysteamine,beta Mercaptoethylamine
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of total ascorbic acid in human serum by high-performance liquid chromatography with fluorescence detection.
November 1985, Journal of chromatography,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
[Determination of serum tryptophan by high performance liquid chromatography with fluorescence detection].
December 2002, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of valproic acid in human serum by high-performance liquid chromatography with fluorescence detection.
September 1999, Biological & pharmaceutical bulletin,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of bestatin in serum by high-performance liquid chromatography with fluorescence detection.
February 1984, Journal of chromatography,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of flurbiprofen in human serum by reverse-phase high-performance liquid chromatography with fluorescence detection.
December 1984, Journal of pharmaceutical sciences,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of capsaicin and zucapsaicin in human serum by high-performance liquid chromatography with fluorescence detection.
November 1997, Journal of chromatography. B, Biomedical sciences and applications,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of p-hydroxybestatin in human serum by high-performance liquid chromatography using fluorescence detection.
November 1985, Journal of chromatography,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of nicotinic acid in serum by high-performance liquid chromatography with fluorescence detection.
August 1984, Journal of chromatography,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection.
November 1987, Journal of chromatography,
M Stachowicz, and B Lehmann, and A Tibi, and P Prognon, and V Daurat, and D Pradeau
Melatonin determination in human urine by high-performance liquid chromatography with fluorescence detection.
April 1986, Journal of chromatography,
Copied contents to your clipboard!